The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Vaccination greatly reduces disease, disability, death and inequity worldwide
Open accessAbstract
In low-income countries, infectious diseases still account for a large proportion of deaths, highlighting health inequities largely caused by economic differences. Vaccination can cut health-care costs and reduce these inequities. Disease control, elimination or eradication can save billions of US dollars for communities and countries. Vaccines have lowered the incidence of hepatocellular carcinoma and will control cervical cancer. Travellers can be protected against "exotic" diseases by appropriate vaccination. Vaccines are considered indispensable against bioterrorism. They can combat resistance to antibiotics in some pathogens. Noncommunicable diseases, such as ischaemic heart disease, could also be reduced by influenza vaccination. Immunization programmes have improved the primary care infrastructure in developing countries, lowered mortality in childhood and empowered women to better plan their families, with consequent health, social and economic benefits. Vaccination helps economic growth everywhere, because of lower morbidity and mortality. The annual return on investment in vaccination has been calculated to be between 12% and 18%. Vaccination leads to increased life expectancy. Long healthy lives are now recognized as a prerequisite for wealth, and wealth promotes health. Vaccines are thus efficient tools to reduce disparities in wealth and inequities in health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Home visits: a strategy to improve newborn survival - Authors' reply
(2008) · Americanae (AECID Library) · doi:10.1016/s0140 · Cited by 22,524
Infectious Diseases of Humans: Dynamics and Control
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-174_4 · Cited by 7,746
Algebraic decay in hierarchical graphs
Garcia, A., Sonnino, G., Malek-Mansour, M.-A., & Baras, F. (1997) · doi:10.1023/a · Cited by 5,187
Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis
Ruiz-Palacios, G. M., Pérez-Schael, I., Velázquez, F. R., Abate, H., Breuer, T., Clemens, S. C., Cheuvart, B., Espinoza, F., Gillard, P., Innis, B. L., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052434 · Cited by 1,799
Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
Cutts, F., Zaman, S., Enwere, G., Jaffar, S., Levine, O., Okoko, J., Oluwalana, C., Vaughan, A., Obaro, S., Leach, A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71876-6 · Cited by 900
Kyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051642 · Cited by 881
Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., & Iwane, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025028 · Cited by 752
Poverty and health sector inequalities.
Wagstaff, A. R. (2002) · Europe PMC (PubMed Central) · Cited by 706
Active Bacterial Core Surveillance of the Emerging Infections Program Network
Schuchat, A., Hilger, T., Zell, E., Farley, M. M., Reingold, A., Harrison, L., Lefkowitz, L., Danila, R., Stefonek, K., Barrett, N., et al. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010114 · Cited by 592
Protection Against Hepatitis A by an Inactivated Vaccine
Innis, B. L. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510410040030 · Cited by 417
Ahmed, Q. A., Arabi, Y. M., & Memish, Z. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68429-8 · Cited by 411
The global value of vaccination
Ehreth, J. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00623-0 · Cited by 408
Zhou, W., Pool, V., Iskander, J. K., English-Bullard, R., Ball, R., Wise, R. P., Haber, P., Pless, R., Mootrey, G. T., Ellenberg, S. S., et al. (2003) · PubMed · Cited by 400
Herd immunity and herd effect: new insights and definitions
John, T. J., & Samuel, R. (2000) · European Journal of Epidemiology · doi:10.1023/a:1007626510002 · Cited by 367
Self-citationHepatitis A Transmitted by Food
Fiore, A. E. (2004) · Clinical Infectious Diseases · doi:10.1086/381671 · Cited by 352
Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis
Ali, M., Emch, M., von Seidlein, L., Yunus, M., Sack, D. A., Rao, M., Holmgren, J., & Clemens, J. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66550-6 · Cited by 327
Self-citationNeonatal survival: a call for action
Martines, J., Paul, V. K., Bhutta, Z. A., Koblinsky, M., Soucat, A., Walker, N., Bahl, R., Fogstad, H., & Costello, A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71882-1 · Cited by 314
Cost-effectiveness of a routine varicella vaccination program for U.S. children
(1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70148-2 · Cited by 306
Parker, A. A., Staggs, W., Dayan, G. H., Ortega-Sánchez, I. R., Rota, P. A., Lowe, L., Boardman, P., Teclaw, R., Graves, C., & LeBaron, C. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060775 · Cited by 292
Adegbola, R. A., Secka, O., Lahai, G., Lloyd-Evans, N., Njie, A., Usen, S., Oluwalana, C., Obaro, S., Weber, M., Corrah, T., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66788-8 · Cited by 286
Severe and unrecognised: pertussis in UK infants
Crowcroft, N. S. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.9.802 · Cited by 283
Effectiveness Over Time of Varicella Vaccine
Vázquez, M. (2004) · JAMA · doi:10.1001/jama.291.7.851 · Cited by 282
Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine
Peltola, H., Siitonen, A., Kataja, M. J., Kyrönseppa, H., Simula, I., Mattila, L., Oksanen, P., & Cadoz, M. (1991) · The Lancet · doi:10.1016/0140-6736(91)92590-x · Cited by 272
Self-citationEfficacy of Acellular Pertussis Vaccine in Early Childhood After Household Exposure
Schmitt, H.-J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530250041024 · Cited by 272
Self-citationBloom, D. E., Canning, D., & Weston, M. (2017) · Fighting the Diseases of Poverty · doi:10.4324/9780203791950-8 · Cited by 238
A short history of vaccination
Plotkin, S. L., & Plotkin, S. A. (2013) · Vaccines · doi:10.1016/b978-1-4557-0090-5.00017-3 · Cited by 222
Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory
Banatvala, J., Van Damme, P., & Oehen, S. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00224-3 · Cited by 213
Kirk, G. D., Lesi, O. A., Mendy, M., Akano, A. O., Sam, O., Goedert, J. J., Hainaut, P., Hall, A. J., Whittle, H., & Montesano, R. (2004) · Hepatology · doi:10.1002/hep.20027 · Cited by 210
Flannery, B. (2004) · JAMA · doi:10.1001/jama.291.18.2197 · Cited by 180
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Christenson, B., Hedlund, J., Lundbergh, P., & Örtqvist, Å. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00063504 · Cited by 162
Mumps and rubella eliminated from Finland
Peltola, H. (2000) · JAMA · doi:10.1001/jama.284.20.2643 · Cited by 134
Self-citationThe Efficacy of Influenza Vaccine for Healthy Children
Manzoli, L., Schioppa, F. S., Boccia, A., & Villari, P. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000253053.01151.bd · Cited by 120
Appropriate antibiotic use and why it is important: the challenges of bacterial resistance
Lieberman, J. M. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000101851.57263.63 · Cited by 114
Impact of vaccines universally recommended for children--United States, 1990-1998.
(1999) · PubMed · Cited by 110
Protection against hepatitis A by an inactivated vaccine.
Innis, B. L., Snitbhan, R., Kunasol, P., et al. (1994) · PubMed · Cited by 104
Folb, P. I., Bernatowska, E. A., Chen, R. E., Clemens, J. D., Dodoo, A. N. O., Ellenberg, S. S., Farrington, P., John, T., Lambert, P., MacDonald, N. E., et al. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.11.1926 · Cited by 97
Self-citationRuff, T., Gertig, D. M., Otto, B., Gust, I. D., Sutanto, A., Soewarso, T. I., Kandun, N., Marschner, I. C., & Maynard, J. E. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.2.290 · Cited by 82
Self-citationMeasles Herd Immunity: The Association of Attack Rates With Immunization Rates in Preschool Children
Schlenker, T. L. (1992) · JAMA · doi:10.1001/jama.267.6.823 · Cited by 80
Chang, M. (2003) · Liver International · doi:10.1034/j.1478-3231.2003.00865.x · Cited by 77
Decker, M. D. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200111001-00002 · Cited by 77
Schmitt, H., von Kries, R., HASSENPFLUG, B., HERMANN, M., Siedler, A., NIESSING, W., Clemens, R. L., & WEIL, J. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200108000-00010 · Cited by 73
Self-citationMuller, C. P., Kremer, J. R., Best, J. M., Dourado, I. C., Triki, H., & Reef, S. E. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.07.039 · Cited by 70
Moulton, L. H., Chung, S.-E., Croll, J., Reid, R., Weatherholtz, R., & Santosham, M. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.4.753 · Cited by 68
Self-citationArístegui, J., Usonis, V., Coovadia, H. M., Riedemann, S., Win, K. M., GATCHALIAN, S. R., & Bock, H. L. (2003) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(03)90011-7 · Cited by 62
Self-citationMeasles vaccination improves the equity of health outcomes: evidence from Bangladesh
Bishai, D. M., Koenig, M., & Khan, M. A. (2002) · Health Economics · doi:10.1002/hec.732 · Cited by 50
A Short History of Vaccination
Plotkin, S. L., & Plotkin, S. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00001-3 · Cited by 43
The societal value of universal childhood vaccination
Chabot, I., Goetghebeur, M. M., & Grégoire, J. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.10.027 · Cited by 40
Immunization myths and realities: Responding to arguments against immunization
MacIntyre, C. R., & Leask, J. (2003) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.2003.t01-1-00200.x · Cited by 40
Parry, C. M. (2004) · Current Infectious Disease Reports · doi:10.1007/s11908-004-0021-6 · Cited by 35
Vaccines for the prevention of diseases caused by potential bioweapons
Hassani, M., Patel, M. C., & Pirofski, L. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.09.010 · Cited by 31
Global poliomyelitis eradication: status and implications
Fine, P., & Griffiths, U. K. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60533-9 · Cited by 28
The societal value of vaccination in developing countries
Shearley, A. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00303-5 · Cited by 24
Cited by
Toll-like Receptors and the Control of Immunity
Fitzgerald, K. A., & Kagan, J. C. (2020) · Cell · doi:10.1016/j.cell.2020.02.041 · Cited by 2,168
The global burden of neurological disorders: translating evidence into policy
Feigin, V. L., Vos, T., Nichols, E., Owolabi, M. O., Carroll, W. M., Dichgans, M., Deuschl, G., Parmar, P., Brainin, M., & Murray, C. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30411-9 · Cited by 1,303
Puri, N., Coomes, E. A., Haghbayan, H., & Gunaratne, K. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1780846 · Cited by 1,157
Attitudes to vaccination: A critical review
Yaqub, O., Castle-Clarke, S., Sevdalis, N., & Chataway, J. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.04.018 · Cited by 1,089
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19
Neumann-Böhme, S., Varghese, N. E., Sabat, I., Barros, P. P., Brouwer, W., van Exel, J., Schreyögg, J., & Stargardt, T. (2020) · The European Journal of Health Economics · doi:10.1007/s10198-020-01208-6 · Cited by 1,011
Metadata
- Authors
- Andre, F., Booy, R., Bock, H., Clemens, J., Datta, S., John, T., Lee, B., Lolekha, S., Peltola, H., Ruff, T., Santosham, M., & Schmitt, H.
- Venue
- Bulletin of the World Health Organization
- Publisher
- WHO Press
- Published
- 2008-02-01
- Volume
- 86
- Issue
- 2
- Pages
- 140-146
- ISSN
- 0042-9686 (ISSN-L)
- OpenAlex
- W2162555339
- Cited by
- 1,234
- References
- 54
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.